SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017408
Filing Date
2022-11-10
Accepted
2022-11-10 16:07:10
Documents
51
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acxp-20220930x10q.htm   iXBRL 10-Q 1463990
2 EX-31.1 acxp-20220930xex31d1.htm EX-31.1 12640
3 EX-31.2 acxp-20220930xex31d2.htm EX-31.2 12645
4 EX-32.1 acxp-20220930xex32d1.htm EX-32.1 5517
5 EX-32.2 acxp-20220930xex32d2.htm EX-32.2 5555
  Complete submission text file 0001558370-22-017408.txt   4345367

Data Files

Seq Description Document Type Size
6 EX-101.SCH acxp-20220930.xsd EX-101.SCH 33662
7 EX-101.CAL acxp-20220930_cal.xml EX-101.CAL 18612
8 EX-101.DEF acxp-20220930_def.xml EX-101.DEF 136697
9 EX-101.LAB acxp-20220930_lab.xml EX-101.LAB 287008
10 EX-101.PRE acxp-20220930_pre.xml EX-101.PRE 232816
45 EXTRACTED XBRL INSTANCE DOCUMENT acxp-20220930x10q_htm.xml XML 427494
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40536 | Film No.: 221377105
SIC: 2834 Pharmaceutical Preparations